Presented ByProf. Bertram Glass, Helios Klinikum Berlin-Buch, Germany
TrialPhase 2, ASTRAL ConferenceASH 2023
7 February, 2024 15:00
Presented ByDr Paolo Strati, MD Anderson Cancer Center, TX, USA
TrialPhase 2 ConferenceASH 2023
7 February, 2024 15:00
Presented ByDr Charalambos Andreadis, University of California San Francisco, USA
TrialPhase 3, A051301/BMT-CTN 1201 ConferenceASH 2023
7 February, 2024 14:59
Presented ByDr Elizabeth Budde, City of Hope National Medical Center, CA, USA
TrialPhase 1/2 ConferenceASH 2023
7 February, 2024 14:59
Presented ByProf. Michael Wang, University of Texas, TX, USA
TrialPhase 3, SYMPATICO ConferenceASH 2023
7 February, 2024 14:59
ExpertProf. Marc Bonaca, University of Colorado, USA
4 January, 2024 15:06
ExpertLorna Warwick, Lymphoma Coalition
14 September, 2023 09:16
Presented ByDr Takahiro Kumode, Kindai University, Japan
TrialPhase 2, MIRAGE ConferenceEHA 2023
2 August, 2023 16:05
Presented ByDr Katy Rezvani, MD Anderson Cancer Center, TX, USA
ConferenceEBMT 2023
15 June, 2023 17:20
Presented ByDr Anna Sureda, Catalan Institute of Oncology, Spain
ConferenceEBMT 2023
15 June, 2023 17:15
Presented ByProf. Tomas Neilan, Massachusetts General Hospital, MA, USA
TrialPhase 2, STOP-CA ConferenceACC 2023
7 June, 2023 09:58
Presented ByProf. Gerald Illerhaus, Klinikum Stuttgart, Germany
TrialPhase 3, MATRix/IELSG43 ConferenceASH 2022
20 February, 2023 12:37
Presented ByProf. Won-Seog Kim, Samsung Medical Center, South Korea
TrialPhase 2, ELM-2 trial ConferenceASH 2022
20 February, 2023 12:30
Presented ByDr Yago Nieto, University of Texas, TX, USA
ConferenceASH 2022
20 February, 2023 12:27
Presented ByDr Kai Rejeski, LMU Munich, Germany
ConferenceASH 2022
20 February, 2023 12:23
Presented ByProf. Michael Wang, Anderson Cancer Center, TX, USA
TrialPhase 3, SHINE ConferenceASCO 2022
5 August, 2022 14:30
Presented ByProf. Martine Chamuleau, Amsterdam UMC, the Netherlands
TrialPhase 3, HOVON/SAKK ConferenceEHA 2022
1 July, 2022 11:32
ExpertDr Kelly Kenzik, Institute for Cancer Outcomes and Survivorship, University of Alabama, USA
ConferenceASH 2021
4 February, 2022 11:36
ExpertDr Matthew J. Frank, Stanford University School of Medicine, USA
ConferenceASH 2021
4 February, 2022 11:30
ExpertDr Sattva S. Neelapu, MD Anderson Cancer Center, Houston, USA
TrialZUMA-12 ConferenceASH 2021
4 February, 2022 11:25
ExpertDr Grzegorz Nowakowski, Mayo Clinic, Rochester, USA
TrialCohort study, RE-MIND2 ConferenceASH 2021
4 February, 2022 11:08
ExpertDr Manali Kamdar, University of Colorado Cancer Center, Denver, USA
TrialPhase 3, TRANSFORM ConferenceASH 2021
4 February, 2022 10:28
ExpertDr Geoffrey Shouse, City of Hope Comprehensive Cancer Center, USA
ConferenceASH 2021
4 February, 2022 10:20
ExpertDr Frederick Locke, Moffitt Cancer Cancer, Tampa, Florida, USA
TrialPhase 3, ZUMA-7 ConferenceASH 2021
4 February, 2022 10:10
ExpertDr Michael R. Bishop, David and Etta Jonas Center for Cellular Therapy, University of Chicago, USA
TrialPhase 3, BELINDA ConferenceASH 2021
4 February, 2022 10:03
ExpertDr Mahmoud Elsawy, Dalhousie University, Halifax, USA
TrialPhase 3, ZUMA-7 ConferenceASH 2021
4 February, 2022 09:48
Presented ByDr Ismael Fernández-Miranda, Institute of Sanitary Investigation Puerta de Hierro, Spain & Dr Shan-Shan Li, Hospital of Sun Yat-sen University, China
ConferenceESMO 2021
19 November, 2021 09:19
Presented ByDr Liudmila Fedorova, Pavlov University, Russia
ConferenceESMO 2021
19 November, 2021 09:18
Presented ByDr Laurie Sehn, University of British Columbia, Vancouver, Canada
TrialPhase 3, ESCALADE JournalPhysician's Weekly ConferenceASCO 2021
6 August, 2021 12:36
Presented ByDr Marc André, Centre Hospitalier Universitaire UCL Namur, Belgium
TrialCheckMate 205; KEYNOTE-087 ConferenceEHA 2021
5 August, 2021 12:26
Presented ByDr Gerald Illerhaus, Klinikum der Landeshauptstadt Stuttgart, Germany
TrialPhase 2, IELSG32 ConferenceEHA 2021
5 August, 2021 12:05
Presented ByDr Moshe Yair Levy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, USA
ConferenceEHA 2021
5 August, 2021 11:55
Presented ByDr Bastian von Tresckow, University Hospital Essen, Germany
TrialZUMA-5; ELARA ConferenceEHA 2021
5 August, 2021 11:47
Presented ByProf. John Gribben, Barts Cancer Institute, UK
TrialZUMA-5; SCHOLAR-5 ConferenceEHA 2021
5 August, 2021 11:18
Presented ByProf. Marco Ladetto, University del Piemonte Orientale, Italy
TrialLOTIS-2 ConferenceEHA 2021
5 August, 2021 11:17
Presented ByDr Robbie Majzner, Stanford University, California, USA
ConferenceASH 2020
18 February, 2021 10:15
Presented ByDr Susanne Ghandili, University Medical Center Hamburg-Eppendorf, Germany
ConferenceASH 2020
18 February, 2021 09:34
Presented ByDr Peter Borchmann, University Hospital of Cologne, Germany
TrialPhase 3, HD17 ConferenceEHA 2020
9 September, 2020 12:51
Presented ByProf. Pier Luigi Zinzani, University of Bologna, Italy
TrialPhase 3, KEYNOTE-204 ConferenceEHA 2020
9 September, 2020 12:38
Presented ByDr Martin Hutchings, Copenhagen University Hospital, Denmark
TrialPhase 1/2, GEN3013 ConferenceEHA 2020
9 September, 2020 12:30
Presented ByProf. Elias Jabbour , University of Texas MS Anderson Cancer Centre, USA
TrialPhase 1 ConferenceEHA 2020
28 August, 2020 12:23
Presented ByProf. Christine Mauz-Körholz, Justus-Liebig-Universität Gießen, Germany
TrialPhase 2, Checkmate 744 ConferenceEHA 2020
28 August, 2020 12:09
Presented ByProf. Stephen Schuster, University of Pennsylvania, USA
ConferenceASH 2019
5 March, 2020 09:50
Presented ByDr Jode Goodridge, Fate Therapeutics, USA
ConferenceASH 2019
5 March, 2020 09:38
Presented ByDr Steven Horwitz , Memorial Sloan Kettering Cancer Center, USA
TrialPhase 3, ECHELON-1 ConferenceEHA 2019
9 August, 2019 20:49
Presented ByDr Roberta Di Blasi, Hospital Saint-Louis, France
TrialJULIET and ZUMA1 ConferenceEHA 2019
9 August, 2019 19:55
Presented ByProf. Wojciech Jurczak, Jagiellonian University, Poland
ConferenceEHA 2019
9 August, 2019 17:13
Presented ByProf. Mark Lebwohl, Mount Sinai School of Medicine, USA
ConferenceAAD 2019
19 April, 2019 14:06